Literature DB >> 1617892

Pulmonary hypertension in MCTD: report of two cases with anticardiolipin antibody.

M Miyata1, S Kida, T Kanno, K Suzuki, H Watanabe, S Kaise, T Nishimaki, Y Hosoda, R Kasukawa.   

Abstract

We report on 2 patients with well-documented mixed connective tissue disease (MCTD) accompanied by severe pulmonary hypertension (PH) due to thrombosis or thromboembolism. In a previous report we indicated (1) that patients with MCTD complicated by PH have a significantly worse prognosis than patients with other connective tissue disease (CTD) complicated by PH. Both our patients had anticardiolipin antibody (a-CL) in the initial stages of the disease. We also studied the relationship of a-CL to PH in patients with other CTD. Patients of either MCTD or SLE with high levels of a-CL had significantly higher values of mean pulmonary arterial pressure than patients without a-CL. Several factors were suggested for the pathogenesis of PH such as vasospasm, arteritis, platelet dysfunction, and thrombosis or thromboembolism. The presence of a-CL may be one of important factors in development of PH among patients with MCTD with recurrent pulmonary thrombosis or thromboembolism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1617892     DOI: 10.1007/bf02207956

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  28 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Pulmonary hypertension in connective tissue disease. Clinical analysis of sixty patients in multi-institutional study.

Authors:  R Kasukawa; T Nishimaki; T Takagi; S Miyawaki; R Yokohari; T Tsunematsu
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

3.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 4-1973.

Authors: 
Journal:  N Engl J Med       Date:  1973-01-25       Impact factor: 91.245

4.  Pulmonary hypertension in systemic sclerosis.

Authors:  E Trell; C Lindström
Journal:  Ann Rheum Dis       Date:  1971-07       Impact factor: 19.103

5.  Pulmonary hypertension in systemic lupus erythematosus.

Authors:  R A Asherson; C G Mackworth-Young; M L Boey; R G Hull; A Saunders; A E Gharavi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

6.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

7.  Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus.

Authors:  F P Quismorio; O Sharma; M Koss; T Boylen; A W Edmiston; P J Thornton; D Tatter
Journal:  Semin Arthritis Rheum       Date:  1984-05       Impact factor: 5.532

8.  Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis.

Authors:  D E Furst; J A Davis; P J Clements; S K Chopra; A N Theofilopoulos; D Chia
Journal:  Arthritis Rheum       Date:  1981-11

9.  Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma).

Authors:  R Salerni; G P Rodnan; D F Leon; J A Shaver
Journal:  Ann Intern Med       Date:  1977-04       Impact factor: 25.391

Review 10.  Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature.

Authors:  H D Perez; N Kramer
Journal:  Semin Arthritis Rheum       Date:  1981-08       Impact factor: 5.532

View more
  1 in total

1.  [Cardiovascular monitoring of patients with systemic lupus erythematosus].

Authors:  H Schotte; H Becker; W Domschke; M Gaubitz
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.